Dr Arjun Oberoi
In his capacity as Vice Chairman, Arjun is responsible for architecting the overall strategic plan for the Everlife platform, including M&A strategy, country / product focus, leadership development at both Everlife Group and portfolio company levels and integration model across our portfolio assets to maximise synergies.
Arjun has 15+ years of leadership experience in major healthcare MNCs such as Stryker, Sanofi and Pfizer. He has played both operational and Business Development / M&A roles in the US and Asia-Pacific with a strong track-record of acquiring and integrating multiple Pharma and Medtech businesses in Asia. He was the global head of healthcare for Actis, a leading growth markets private equity fund which has raised more than USD 13 billion since inception and founded Cure Capital in 2017.
Arjun is a board certified physician in the UK and began his corporate career as a consultant with McKinsey.
Arjun holds a BSc in Neuroscience and a MD in Medicine from the University of Edinburgh.
Chief Executive Officer
Raman will provide leadership in the overall performance of the Everlife platform, including M&A strategy, driving company and principal performance and realizing synergies across Everlife’s portfolio of companies.
Raman has over 25 years of experience across the Pharmaceutical, Hospital Healthcare and Medical Device sectors with leading healthcare MNCs in Asia.
In his previous position as Senior Vice President for India & South-East Asia with Smith & Nephew, Raman built a foundation of strong growth, sustainably gaining shares across businesses in five years while increasing margins.
Raman brings expertise in developing and executing business growth strategies across industry segments and geographies.
Over the course of two decades he has built strong teams in complex dynamic environments, delivering sustainable financial and operating success. Prior to Smith & Nephew, he held leadership roles at Baxter and Allergan.
Chief Financial Officer
Anand has over 20 years of global experience in premier fortune 500 companies, private equity and owner managed business houses, specializing in organizational transformation, turnarounds and acquisition integration.
Anand will be responsible for delivering value creation strategies for Everlife and its portfolio companies, including stewardship of platform assets, financial governance & reporting and process optimization.
Prior to joining Everlife, Anand served as Senior Advisor to TPG Capital Asia and was the Global Finance Director for Tyco’s Fire Suppression Division.
Anand holds an MBA from UCLA’s Anderson School of Management and The National University of Singapore. Anand is also a qualified Chartered Accountant.
Head of Business Development and M&A
Dr Amit Kakar
As Head of Business Development and M&A , Amit provides overall leadership for product vertical and segment expertise. He is responsible for product sourcing, validation and principal engagements for Everlife’s platform companies. He also leads M&A initiatives, where he is responsible for identification and diligence of potential targets. He has over 30 years of healthcare experience including clinical, operational, M&A, MedTech and investment expertise. At GE Healthcare, he held several senior leadership roles in India, US and China over a period of 14 years.
Amit also was the Asia head of Healthcare Investments at Avenue Capital, where he invested in China and India over a period of 7 years. He also currently sits on the board of 2 healthcare companies.
Amit is a physician by training and holds a postgraduate degree in Nuclear Medicine from Tata Memorial Hospital, Mumbai, India
In her capacity as VP of Operations, Chermayn works with Everlife’s portfolio companies to optimize operational efficiencies.
Chermayn has spent 14 years working in the healthcare industry throughout the region. She started her career in market research, before joining the Sanofi Business Development team leading regional asset licensing projects.
In 2010, she moved to China to manage Sanofi’s outsourced portfolio and lead license-in projects. Prior to joining Everlife, she was Director of Operations for a genetic testing start-up in Shanghai.
Chermayn graduated from the University of Pennsylvania with a double major in Biology, and Economics.
Fabian has 4 years of work experience in private equity in Southeast Asia.
Prior to joining Everlife, he was an associate with Hera Capital Partners, a Singapore-based private equity firm focused on investments in the consumer retail, media and digital sectors of Southeast Asia.
He has a Bachelor in Business Administration from National University of Singapore and is a CFA charterholder.
Clady is the Everlife team’s Executive Assistant, supporting the platform and portfolios on office management, secretarial and administrative matters.
Clady brings with her more than 10 years of experience in a broad range of roles including sales, service, and executive support.